Signatera Wins Fierce Life Sciences Innovation Award
AUSTIN, Texas, Jan. 3, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that its personalized molecular r…
AUSTIN, Texas, Jan. 3, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that its personalized molecular r…